• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心力衰竭患者在正常充盈压下维持心输出量。

Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure.

作者信息

Stevenson L W, Tillisch J H

出版信息

Circulation. 1986 Dec;74(6):1303-8. doi: 10.1161/01.cir.74.6.1303.

DOI:10.1161/01.cir.74.6.1303
PMID:3779915
Abstract

Therapy of elevated ventricular filling pressures in patients with dilated heart failure may be limited by concern that cardiac output will be further compromised. Twenty-five patients with severe symptoms and ejection fractions of 25% or less were studied to determine the lowest ventricular filling pressures that could be achieved with vasodilator and diuretic therapy while maintaining cardiac output. In 20 of 25 patients normal pulmonary capillary wedge pressures (PCWs) were achieved (mean 10 mm Hg compared with 30 mm Hg at baseline). Stroke volume was 60 vs 39 ml at baseline. Stroke work index was 30 vs 19 g-m/m2. For each patient, over the range of PCWs, stroke volume and stroke work index were maintained and were often maximal at the lowest PCW achieved. The upright position was well tolerated in patients with normal supine PCW. Normal filling pressures can be achieved in patients with congestive heart failure without compromise of cardiac output. While congestive symptoms should be improved, the feasibility and benefit of maintaining normal filling pressures over a long term must be established.

摘要

扩张型心力衰竭患者心室充盈压升高的治疗可能会受到担心心输出量会进一步受损的限制。对25例有严重症状且射血分数为25%或更低的患者进行了研究,以确定在维持心输出量的同时,使用血管扩张剂和利尿剂治疗所能达到的最低心室充盈压。25例患者中有20例达到了正常的肺毛细血管楔压(PCW)(平均10 mmHg,而基线时为30 mmHg)。每搏量在基线时为39 ml,达到正常PCW时为60 ml。每搏功指数在基线时为19 g-m/m²,达到正常PCW时为30 g-m/m²。对于每例患者,在PCW范围内,每搏量和每搏功指数得以维持,且常在达到的最低PCW时最大。仰卧位PCW正常的患者能很好地耐受直立位。充血性心力衰竭患者可在不损害心输出量的情况下达到正常充盈压。虽然充血症状应会改善,但长期维持正常充盈压的可行性和益处仍有待确定。

相似文献

1
Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure.扩张型心力衰竭患者在正常充盈压下维持心输出量。
Circulation. 1986 Dec;74(6):1303-8. doi: 10.1161/01.cir.74.6.1303.
2
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.针对晚期心力衰竭幸存者量身定制的降低充盈压治疗的持续血流动力学疗效。
Circulation. 1997 Aug 19;96(4):1165-72. doi: 10.1161/01.cir.96.4.1165.
3
Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.硝普钠在慢性缺血性心脏病中的临床应用。对周围血管阻力、静脉张力以及心室容积、泵功能和机械性能的影响。
Circulation. 1975 Feb;51(2):328-36. doi: 10.1161/01.cir.51.2.328.
4
[Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].[血管扩张剂治疗急性心肌梗死的血流动力学指南]
Acta Med Austriaca Suppl. 1979;15:1-34.
5
Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.后负荷降低(利尿剂和血管扩张剂)对缺血性或特发性扩张型心肌病所致严重充血性心力衰竭患者左心室容积及二尖瓣反流的影响。
Am J Cardiol. 1987 Sep 15;60(8):654-8. doi: 10.1016/0002-9149(87)90376-6.
6
Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy.运动血流动力学变量在冠状动脉疾病或扩张型心肌病继发的慢性充血性心力衰竭中的增量预后价值。
Am J Cardiol. 1991 Apr 15;67(9):848-53. doi: 10.1016/0002-9149(91)90618-u.
7
Vasodilator therapy of dilated cardiomyopathy.扩张型心肌病的血管扩张剂治疗
Postgrad Med J. 1986 Jun;62(728):599-600. doi: 10.1136/pgmj.62.728.599.
8
The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.正性肌力药和血管扩张剂疗法对充血性心肌病患者舒张功能的不同影响。
Circulation. 1986 Oct;74(4):815-25. doi: 10.1161/01.cir.74.4.815.
9
Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Am J Cardiol. 1979 Jul;44(1):126-31. doi: 10.1016/0002-9149(79)90261-3.
10
Acute hemodynamic effects of sildenafil in patients with idiopathic dilated cardiomyopathy.西地那非对特发性扩张型心肌病患者的急性血流动力学影响。
Indian Heart J. 2008 Nov-Dec;60(6):599-601.

引用本文的文献

1
Emerging use of pulmonary artery and cardiac pressure sensing technology in the management of worsening heart failure events.肺动脉和心脏压力传感技术在恶化性心力衰竭事件管理中的新应用。
Heart Fail Rev. 2025 May 9. doi: 10.1007/s10741-025-10513-2.
2
Hemodynamic management of cardiogenic shock in the intensive care unit.重症监护病房心源性休克的血流动力学管理。
J Heart Lung Transplant. 2024 Jul;43(7):1059-1073. doi: 10.1016/j.healun.2024.03.009. Epub 2024 Mar 20.
3
Myocardial Oedema as a Consequence of Viral Infection and Persistence-A Narrative Review with Focus on COVID-19 and Post COVID Sequelae.
心肌水肿作为病毒感染和持续存在的后果——以 COVID-19 和新冠后遗症为重点的叙述性综述。
Viruses. 2024 Jan 14;16(1):121. doi: 10.3390/v16010121.
4
Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management.左心疾病相关肺动脉高压:病理生理学、血流动力学评估与治疗管理。
Int J Mol Sci. 2023 Jun 9;24(12):9971. doi: 10.3390/ijms24129971.
5
Improved diastolic dysfunction is associated with higher forward flow and better prognosis in chronic heart failure.舒张功能障碍改善与慢性心力衰竭中更高的前向血流及更好的预后相关。
Int J Cardiovasc Imaging. 2022 Apr;38(4):727-737. doi: 10.1007/s10554-021-02457-z. Epub 2021 Nov 2.
6
Development and Validation of an Arterial Pressure-Based Cardiac Output Algorithm Using a Convolutional Neural Network: Retrospective Study Based on Prospective Registry Data.基于卷积神经网络的基于动脉压的心输出量算法的开发与验证:基于前瞻性注册数据的回顾性研究
JMIR Med Inform. 2021 Aug 16;9(8):e24762. doi: 10.2196/24762.
7
First-in-Human Experience of Mechanical Preload Control in Patients With HFpEF During Exercise.射血分数保留的心力衰竭(HFpEF)患者运动期间机械预负荷控制的人体首次试验经验
JACC Basic Transl Sci. 2021 Feb 17;6(3):189-198. doi: 10.1016/j.jacbts.2020.12.007. eCollection 2021 Mar.
8
Mavacamten preserves length-dependent contractility and improves diastolic function in human engineered heart tissue.马卡丹特可保持长度依赖性收缩性并改善人工程心脏组织的舒张功能。
Am J Physiol Heart Circ Physiol. 2021 Mar 1;320(3):H1112-H1123. doi: 10.1152/ajpheart.00325.2020. Epub 2021 Jan 15.
9
Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction.肥胖型射血分数保留心力衰竭患者利尿消肿时的肾脏不良反应。
J Card Fail. 2020 Feb;26(2):101-107. doi: 10.1016/j.cardfail.2019.09.015. Epub 2019 Oct 13.
10
Angiotensin-converting-enzyme inhibitors in hemodynamic congestion: a meta-analysis of early studies.血管紧张素转化酶抑制剂在血液动力学性充血中的作用:早期研究的荟萃分析。
Clin Res Cardiol. 2019 Nov;108(11):1240-1248. doi: 10.1007/s00392-019-01456-4. Epub 2019 Mar 20.